You are here

DS-7300

ESMO: Daiichi dazzles in lung cancer to dial up hopes for next ADC

Fierce Biotech

Mon, 09/12/22 - 10:43 am

small cell lung cancer

ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals

Fierce Biotech

Fri, 09/17/21 - 11:06 am

antibody-drug conjugate

Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute

Pharmaceutical Business Review

Fri, 11/1/19 - 10:35 am

Sarah Cannon Research Institute

antibody-drug conjugate

clinical trials